Monoclonal antibodies and recombinant DNA technology: present and future uses in leprosy and tuberculosis.
D000818:Animals; D000911:Antibodies, Monoclonal; D001428:Bacterial Vaccines; D004269:DNA, Bacterial; D004274:DNA, Recombinant; D004893:Erythema Nodosum / Q000276:immunology; D006801:Humans; D006825:Hybridomas; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D007918:Leprosy / Q000276:immunology / Q000517:prevention & control*; D008264:Macrophages / Q000276:immunology; D009161:Mycobacterium / Q000145:classification / Q000235:genetics; D009166:Mycobacterium leprae / Q000276:immunology; D012698:Serologic Tests; D013601:T-Lymphocytes / Q000145:classification; D014376:Tuberculosis / Q000276:immunology / Q000517:prevention & control*
D000911:Antibodies, Monoclonal; D001428:Bacterial Vaccines; D004269:DNA, Bacterial; D004274:DNA, Recombinant; D007130:Immunoglobulin Idiotypes